rediff.com
e.g. Tata motors, Reliance MF, 500570
BSE | NSE

AstraZeneca Pharma India Ltd.

506820 ASTRAZEN Group (A)

23 Jul,09:19
6252.75
9.70 (0.16%)
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Add to Watchlist
 
Day
Wk
Mn
6Mn
Yr
Volume Prev close Day's H/L (Rs.) 52wk H/L (Rs.) Mkt Cap (Rs. Cr)

AstraZeneca Pharma India Ltd.

BUYSELL

6 6,243.05 6,291.00 - 6,252.75 7,550.00 - 3,730.00 15,631.88
NSE | BSE

AstraZeneca Pharma India Ltd.

ASTRAZEN

23 Jul,09:20
6257.65
10.60 (0.17%)
HOW HOT IS THIS STOCK?

Last 15 days data © Rediff.com

Add to Watchlist
 
Day
Wk
Mn
6Mn
Yr
Volume Prev close Day's H/L (Rs.) 52wk H/L (Rs.) Turnover (Rs. Lacs)

AstraZeneca Pharma India Ltd.

BUYSELL

156 6247.05 6,299.80 - 6,249.80 7,572.20 - 3,749.80 9.79

News for AstraZeneca Pharma India Ltd.

Pharma Budget...
Pharma Budget Wish List: Tax Benefits, IP Rights
Pharma industry bodies call for tax incentives, stronger IP regime and R&D support in the upcoming Union Budget to boost domestic growth.
Jul 07, 2024 11:15
AstraZeneca...
AstraZeneca Withdraws COVID Vaccine: Surplus of Updated Vaccines
AstraZeneca is globally withdrawing its COVID-19 vaccine, Covishield, due to a surplus of newer vaccines and declining demand. The company highlights the vaccine's significant role in combating the...
May 08, 2024 14:34
AstraZeneca...
AstraZeneca Withdraws COVID-19 Vaccine: Surplus of Updated Shots
AstraZeneca has withdrawn its COVID-19 vaccine globally due to a surplus of updated vaccines. The company cites a decline in demand for Vaxzevria, which was sold as Covishield in India.
May 08, 2024 11:12
Covaxin Safe, No...
Covaxin Safe, No Side Effects: Bharat Biotech
Bharat Biotech assures Covaxin is safe and effective, with no reported side effects like blood clots, unlike Covishield. Developed with safety as priority, it was rigorously tested.
May 02, 2024 21:41
Lupin Gets USFDA...
Lupin Gets USFDA Approval for Generic Diabetes Drug
Lupin receives USFDA approval to market a generic version of AstraZeneca's Qtern tablets, a medication for type 2 diabetes. The drug will be manufactured at Lupin's Pithampur facility.
Jan 04, 2024 19:17

More News for AstraZeneca Pharma India Ltd. »

(Rs. Crore)

Financial Results of AstraZeneca Pharma India Ltd.

Mar ' 24Mar ' 23Mar ' 22Mar ' 21Mar ' 20
Sales1,295.531,002.97805.60813.56831.81
Operating profit184.45165.1386.17135.47120.69
Interest1.200.630.951.091.14
Gross profit218.05190.5999.99147.22132.54
EPS (Rs)64.6039.7224.6437.3228.88

See more in Research Center »

News for Pharmaceuticals and health care

Sensex Climbs 264...
Sensex Climbs 264 Points Ahead of Budget: Market Update
Indian stock markets rose in early trade on Tuesday, with the Sensex gaining over 264 points ahead of the Union Budget. Find out the key market movers and the impact of FIIs.
Jul 23, 2024 09:50
Sitharaman...
Sitharaman Presents Paperless Budget 2024-25 Using Tablet
Finance Minister Nirmala Sitharaman presented the full Budget 2024-25 in a paperless format, using a digital tablet instead of a traditional briefcase. This marks a continuation of her trend of...
Jul 23, 2024 09:35
India's Economic...
India's Economic Survey: Robust Growth, Inflation & FDI Concerns
India's economic survey shows strong growth but highlights concerns over inflation and FDI inflows, according to economists. Experts also discuss the impact of AI on employment and the need for...
Jul 22, 2024 22:36
Mahindra...
Mahindra Logistics Profit Drops 55% in Q1 FY25
Mahindra Logistics Ltd (MLL) reported a 55% decline in standalone profit to Rs 10.15 crore in the April-June quarter due to higher startup costs and expenses.
Jul 22, 2024 22:30
Mangaluru Airport...
Mangaluru Airport Passenger Traffic Rises 21% | Adani Airports
Mangaluru International Airport sees a 21% surge in passenger traffic in Q1 FY24-25, with Dubai leading international destinations and Bengaluru & Mumbai topping domestic travel. Air India Express...
Jul 22, 2024 22:17

More News »

Top News

Nirmala...
Nirmala Sitharaman to Present 7th Budget, Breaking Record
Finance Minister Nirmala Sitharaman will present her 7th consecutive budget, surpassing the record of Morarji Desai. The budget is expected to focus on post-pandemic fiscal consolidation and...
Jul 23, 2024 09:52
Sensex Climbs 264...
Sensex Climbs 264 Points Ahead of Budget: Market Update
Indian stock markets rose in early trade on Tuesday, with the Sensex gaining over 264 points ahead of the Union Budget. Find out the key market movers and the impact of FIIs.
Jul 23, 2024 09:50
India's Chief...
India's Chief Economic Advisor Criticizes Rich Nations' Climate Hypocrisy
India's Chief Economic Advisor criticizes developed nations for their 'double standards' on climate action, highlighting their high carbon emissions and calls for a balanced approach to climate...
Jul 23, 2024 09:43
Sitharaman...
Sitharaman Presents Paperless Budget 2024-25 Using Tablet
Finance Minister Nirmala Sitharaman presented the full Budget 2024-25 in a paperless format, using a digital tablet instead of a traditional briefcase. This marks a continuation of her trend of...
Jul 23, 2024 09:35
India's Economic...
India's Economic Survey: Robust Growth, Inflation & FDI Concerns
India's economic survey shows strong growth but highlights concerns over inflation and FDI inflows, according to economists. Experts also discuss the impact of AI on employment and the need for...
Jul 22, 2024 22:36

More Top News »

Report Card

PE Ratios
96.58
EPS (Rs.)
64.60
Sales (Rs. Cr)
383.20
Face Value (Rs.)
2
Net Profit Margin (%)
9.89
Last Bonus
1:1
Last Dividend(%)
1200
Return on Average Equity
16.86

Compare 'AstraZeneca Pharma India Ltd.' with other stocks

  • Sun Pharmaceutical Industries Ltd.
  • 1,568.45
  • Compare
  • Divi's Laboratories Ltd.
  • 4,520.10
  • Compare
  • Zydus Lifesciences Ltd.
  • 1,144.60
  • Compare
  • Dr. Reddy's Laboratories Ltd.
  • 6,639.05
  • Compare
  • Torrent Pharmaceuticals Ltd.
  • 2,948.50
  • Compare
  • Apollo Hospitals Enterprise Ltd.
  • 6,385.00
  • Compare
  • Max Healthcare Institute Ltd.
  • 920.05
  • Compare
  • Alkem Laboratories Ltd.
  • 5,138.15
  • Compare

AstraZeneca Pharma India Ltd. performance snapshot

If you had invested Rs.  in AstraZeneca Pharma India Ltd.,     ago

You would have  Rs. 000.00 

Add to Portfolio

Peers

  • LTP
  • Change (Rs.)
  • Change %
  • Mkt Cap (Rs. Cr)
  • Volume
Close
Add AstraZeneca Pharma India Ltd. to your Portfolio
 
 
BSE NSE  
 
Close
Add AstraZeneca Pharma India Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close